KINASE INHIBITION IN RELAPSED/REFRACTORY LEUKEMIA AND LYMPHOMA SETTINGS: RECENT PROSPECTS INTO CLINICAL INVESTIGATIONS

Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations

Cancer is still a major barrier to life expectancy increase worldwide, and hematologic neoplasms represent a relevant percentage of cancer incidence rates.Tumor dependence of continuous proliferative signals mediated through protein kinases overexpression 15-1 shampoo instigated increased strategies of kinase inhibition in the oncologic practice ov

read more